Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Gui

Showing results (221-230 of 251) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|May 22, 2014
Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplantHongnan Mo, Yuankai Shi, Xiaohong Han, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphomaXinrui Chen, Yan Qin, Xuemin Xue, et al.
Chinese Medical Journal|July 24, 2019
A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphomaPeng Liu, Ying Han, Shi-Yu Jiang, et al.
Medicine|February 13, 2016
GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeJing-Jing Wang, Mei Dong, Xiao-Hui He, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 13, 2025
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 studyLin Gui, Xinrui Chen, Wen Zhang, et al.
Immunity, Inflammation and Disease|July 28, 2023
MiR-223-3p affects the proliferation and apoptosis of HCAECs in Kawasaki disease by regulating the expression of FOXP3Ronghao Zheng, Jing Xie, Weijie Li, et al.
Chronic Diseases and Translational Medicine|September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized studyHongnan Mo, Peng Liu, Yan Qin, et al.
Asia-Pacific Journal of Clinical Oncology|January 20, 2017
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicityYouwu Shi, Peng Liu, Shengyu Zhou, et al.
Journal of Translational Medicine|September 21, 2021
Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapyYu Zhou, Shasha Wang, Yunxia Tao, et al.
International Journal of Cancer|May 14, 2020
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroupShiyu Jiang, Yan Qin, Hongxin Jiang, et al.
Pageof 26

Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|May 22, 2014
Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplantHongnan Mo, Yuankai Shi, Xiaohong Han, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphomaXinrui Chen, Yan Qin, Xuemin Xue, et al.
Chinese Medical Journal|July 24, 2019
A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphomaPeng Liu, Ying Han, Shi-Yu Jiang, et al.
Medicine|February 13, 2016
GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeJing-Jing Wang, Mei Dong, Xiao-Hui He, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 13, 2025
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 studyLin Gui, Xinrui Chen, Wen Zhang, et al.
Immunity, Inflammation and Disease|July 28, 2023
MiR-223-3p affects the proliferation and apoptosis of HCAECs in Kawasaki disease by regulating the expression of FOXP3Ronghao Zheng, Jing Xie, Weijie Li, et al.
Chronic Diseases and Translational Medicine|September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized studyHongnan Mo, Peng Liu, Yan Qin, et al.
Asia-Pacific Journal of Clinical Oncology|January 20, 2017
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicityYouwu Shi, Peng Liu, Shengyu Zhou, et al.
Journal of Translational Medicine|September 21, 2021
Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapyYu Zhou, Shasha Wang, Yunxia Tao, et al.
International Journal of Cancer|May 14, 2020
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroupShiyu Jiang, Yan Qin, Hongxin Jiang, et al.
Pageof 26